R-bendamustine in the treatment of nodular lymphocyte predominant Hodgkin lymphoma-An extended follow-up

被引:2
|
作者
Vuolio, Tero [1 ,2 ,3 ]
Kuittinen, Outi [3 ,4 ,5 ]
Vayrynen, Juha P. [6 ,7 ]
Teppo, Hanna-Riikka [6 ,7 ]
Prusil, Roosa E. I. [8 ]
Ramet, Maria [9 ]
Kuitunen, Hanne [10 ]
Paloneva, Timo [11 ]
Kuusisto, Milla E. L. [1 ,2 ,3 ]
机构
[1] Univ Oulu, Oulu, Finland
[2] Oulu Univ Hosp, Oulu, Finland
[3] Univ Eastern Finland, Inst Clin Med, Fac Hlth Med, Kuopio, Finland
[4] Oulu Univ Hosp, Dept Oncol & Radiotherapy, Oulu, Finland
[5] Kuopio Univ Hosp, Canc Ctr, Kuopio, Finland
[6] Univ Oulu, Oulu Univ Hosp, Med Res Ctr Oulu, Dept Pathol, Oulu, Finland
[7] Univ Oulu, Translat Med Res Unit, Oulu, Finland
[8] Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland
[9] Lansi Pohja Cent Hosp, Kemi, Finland
[10] Oulu Univ Hosp, Canc Ctr, Oulu, Finland
[11] Cent Ostrobothnian Cent Hosp, Kokkola, Finland
关键词
RITUXIMAB; MANAGEMENT; THERAPY; DISEASE; TRIAL;
D O I
10.1111/bjh.18896
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E24 / E26
页数:3
相关论文
共 50 条
  • [41] Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?
    Fanale, Michelle
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 406 - 413
  • [42] Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma
    Fanale, Michelle A.
    Cheah, Chan Yoon
    Rich, Amy
    Medeiros, L. Jeffrey
    Lai, Chao-Ming
    Oki, Yasuhiro
    Romaguera, Jorge E.
    Fayad, Luis E.
    Hagemeister, F. B.
    Samaniego, Felipe
    Rodriguez, Maria A.
    Neelapu, Sattva S.
    Lee, Hun J.
    Nastoupil, Loretta
    Fowler, Nathan H.
    Turturro, Francesco
    Westin, Jason R.
    Wang, Michael L.
    McLaughlin, Peter
    Pinnix, Chelsea C.
    Milgrom, Sarah A.
    Dabaja, Bouthaina
    Horowitz, Sandra B.
    Younes, Anas
    BLOOD, 2017, 130 (04) : 472 - 477
  • [43] Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Fuchs, Michael
    Sasse, Stephanie
    Baues, Christian
    Boell, Boris
    von Tresckow, Bastian
    Diehl, Volker
    Borchmann, Peter
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) : 698 - +
  • [44] Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse
    Bein, Julia
    Thurner, Lorenz
    Hansmann, Martin-Leo
    Hartmann, Sylvia
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (12) : 1495 - 1502
  • [45] A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma
    Strobbe, L.
    Valke, L. L. F. G.
    Diets, I. J.
    van den Brand, M.
    Aben, K.
    Raemaekers, J. M. M.
    Hebeda, K. M.
    van Krieken, J. H. J. M.
    ANNALS OF HEMATOLOGY, 2016, 95 (03) : 417 - 423
  • [46] Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up
    Chen, Ronald C.
    Chin, Michael S.
    Ng, Andrea K.
    Feng, Yang
    Neuberg, Donna
    Silver, Barbara
    Pinkus, Geraldine S.
    Stevenson, Mary Ann
    Mauch, Peter M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 136 - 141
  • [47] High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Karuturi, Meghan
    Hosing, Chitra
    Fanale, Michelle
    Medeiros, L. Jeffrey
    Alousi, Amin M.
    de Lima, Marcos J.
    Qazilbash, Muzaffar H.
    Kebriaei, Partow
    Younes, Anas
    Khouri, Issa
    Andersson, Borje S.
    Champlin, Richard
    Anderlini, Paolo
    Popat, Uday
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (06) : 991 - 994
  • [48] Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience
    Gemici, Aliihsan
    Aydogdu, Ismet
    Terzi, Hatice
    Sencan, Mehmet
    Aslan, Alma
    Kaya, Ali Hakan
    Dal, Mehmet Sinan
    Akay, Meltem Olga
    Dogu, Mehmet Hilmi
    Ayyildiz, Orhan
    Sahin, Fahri
    Cagliyan, Gulsum Akgun
    Yilmaz, Mehmet
    Gokgoz, Zafer
    Bilen, Yusuf
    Demir, Cengiz
    Sevindik, Omur Gokmen
    Korkmaz, Serdal
    Eser, Bulent
    Altuntas, Fevzi
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 116 - 120
  • [49] CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma
    Venkataraman, Girish
    Raffeld, Mark
    Pittaluga, Stefania
    Jaffe, Elaine S.
    HISTOPATHOLOGY, 2011, 58 (05) : 803 - 805
  • [50] Nodular lymphocyte-predominant Hodgkin lymphoma revisited: current management strategies and future perspectives
    Eichenauer, Dennis A.
    Borchmann, Peter
    LEUKEMIA & LYMPHOMA, 2024,